¿ A news item on Antigenics Inc. in the Feb. 6, 2001, issue of BioWorld Today should have reported that AG-701 is the first infectious disease product to be evaluated in the clinic using its heat shock protein technology, not that it was the first heat shock protein product in the clinic.

¿ A story in the Feb. 6, 2001, issue of BioWorld Today should have said QLT Inc. received an approvable letter for a new indication for Visudyne, not an approval letter.

Editor's Note: The corrections were made in BioWorld Online.